<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816398</url>
  </required_header>
  <id_info>
    <org_study_id>01-0012-01</org_study_id>
    <nct_id>NCT02816398</nct_id>
  </id_info>
  <brief_title>Catheter System Feasibility Clinical Trial</brief_title>
  <official_title>Vessel-Select Catheter System Feasibility Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility clinical study to evaluate the safety and effectiveness of the catheter system&#xD;
      for the percutaneous creation of an arteriovenous fistula for patients with end stage renal&#xD;
      disease requiring dialysis access.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Sufficient Patency for Clinical Access</measure>
    <time_frame>6 weeks</time_frame>
    <description>Arteriovenous fistula is patent as determined by auscultation or ultrasound and eligible for maturation assistance to achieve clinical access flow rate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients Achieving Dialysis Access</measure>
    <time_frame>6 weeks</time_frame>
    <description>Arteriovenous fistula is mature and patient has started dialysis using the fistula</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients on Dialysis Using the Arteriovenous Fistula or Has Adequate Access Flow Rate to Allow Dialysis</measure>
    <time_frame>3 months</time_frame>
    <description>Arteriovenous fistula is mature or has achieved a minimum clinically acceptable access flow rate as determined by doppler ultrasound assessment to support dialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Requiring Additional Interventions to Achieve Maturation and Dialysis Access</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of patients requiring additional interventions to achieve maturation and initiation of dialysis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous creation of an arteriovenous fistula</intervention_name>
    <description>Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients deemed medically eligible for AV fistula creation per institutional&#xD;
             guidelines and/or clinical judgment&#xD;
&#xD;
          -  Patients diagnosed with chronic kidney disease classification stage IV or V&#xD;
&#xD;
          -  Adequate quality vein &gt;= 2 mm with confirmed clinically significant outflow based on&#xD;
             pre-operative assessment&#xD;
&#xD;
          -  Adequate quality radial artery &gt;= 2 mm based on pre-operative assessment&#xD;
&#xD;
          -  Adequate collateral arterial perfusion&#xD;
&#xD;
          -  Radial artery-adjacent vein proximity &lt; = 1.5 mm&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  Able to travel to institution for follow up examination&#xD;
&#xD;
          -  Able to intraoperatively place an .014&quot; guidewire in artery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Suspected skin disease&#xD;
&#xD;
          -  Immunocompromised patients (e.g. HIV positive)&#xD;
&#xD;
          -  Edema of extremities&#xD;
&#xD;
          -  Current diagnosis of carcinoma&#xD;
&#xD;
          -  Pregnancy or currently breast feeding&#xD;
&#xD;
          -  Diagnosed hypercoaguable state&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Evidence of vascular disease at target site&#xD;
&#xD;
          -  Pre-existing vascular disease that could confound study results&#xD;
&#xD;
          -  Vessel tortuosity or spasm preventing placement of .014&quot; guidewire&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <results_first_submitted>June 25, 2018</results_first_submitted>
  <results_first_submitted_qc>August 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2020</results_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment</title>
          <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment</title>
          <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.5" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Sufficient Patency for Clinical Access</title>
        <description>Arteriovenous fistula is patent as determined by auscultation or ultrasound and eligible for maturation assistance to achieve clinical access flow rate.</description>
        <time_frame>6 weeks</time_frame>
        <population>Patency at 6 weeks</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Sufficient Patency for Clinical Access</title>
          <description>Arteriovenous fistula is patent as determined by auscultation or ultrasound and eligible for maturation assistance to achieve clinical access flow rate.</description>
          <population>Patency at 6 weeks</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Achieving Dialysis Access</title>
        <description>Arteriovenous fistula is mature and patient has started dialysis using the fistula</description>
        <time_frame>6 weeks</time_frame>
        <population>Patients on dialysis at 6 weeks</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Achieving Dialysis Access</title>
          <description>Arteriovenous fistula is mature and patient has started dialysis using the fistula</description>
          <population>Patients on dialysis at 6 weeks</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients on Dialysis Using the Arteriovenous Fistula or Has Adequate Access Flow Rate to Allow Dialysis</title>
        <description>Arteriovenous fistula is mature or has achieved a minimum clinically acceptable access flow rate as determined by doppler ultrasound assessment to support dialysis</description>
        <time_frame>3 months</time_frame>
        <population>Patients on dialysis or achieved suitable access flow rate</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients on Dialysis Using the Arteriovenous Fistula or Has Adequate Access Flow Rate to Allow Dialysis</title>
          <description>Arteriovenous fistula is mature or has achieved a minimum clinically acceptable access flow rate as determined by doppler ultrasound assessment to support dialysis</description>
          <population>Patients on dialysis or achieved suitable access flow rate</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Requiring Additional Interventions to Achieve Maturation and Dialysis Access</title>
        <description>The number of patients requiring additional interventions to achieve maturation and initiation of dialysis.</description>
        <time_frame>12 weeks</time_frame>
        <population>Number of additional interventions to achieve suitability for dialysis</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Requiring Additional Interventions to Achieve Maturation and Dialysis Access</title>
          <description>The number of patients requiring additional interventions to achieve maturation and initiation of dialysis.</description>
          <population>Number of additional interventions to achieve suitability for dialysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected over a period of 6 months from index procedure through arteriovenous fistula maturation</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment</title>
          <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula&#xD;
Percutaneous creation of an arteriovenous fistula: Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <description>Hematoma associated with procedure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>Deaths during study duration. None related to treatment procedure</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Acute thrombosis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Acute thrombosis of anastomosis</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gene Reu</name_or_title>
      <organization>Avenu Medical - Sponsor</organization>
      <phone>949 276 2483 ext 102</phone>
      <email>greu@avenumedical.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

